Joaquina Celebre Baranda

7PUBLICATIONS

25CO-AUTHORS

Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPharmaceutical delivery technologies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 28, 2026

Pancreatic Acinar Cell Carcinoma: A Rare Pancreatic Malignancy with Distinct Biology and Emerging Therapeutic Opportunities.

|Feb 07, 2025

Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.

Qamar J Khan, Colleen Bohnenkamp, Taylor E Monson

|May 02, 2024

Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.

Alice N Weaver, Wade T Iams, Jong Chul Park

|Feb 20, 2024

Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.

Anwaar Saeed, Robin Park, Harsh Pathak

|Sep 28, 2023

Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients.

Ian M Freed, Anup Kasi, Oluwadamilola Fateru

|Jul 17, 2023

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy.

Stijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi

Pageof 2

Frequent Collaborators

Weijing Sun

Stephen Williamson

Andrew K Godwin

Anup Kasi

Raed Moh'd Taiseer Al-Rajabi

Hirva Mamdani

Nitika

Ian M Freed

Prasad Dandawate

Anwaar Saeed

Frequent Collaborators

Weijing Sun

Stephen Williamson

Andrew K Godwin

Anup Kasi